Emcure Pharmaceuticals Ltd Screener
Emcure Pharma Investment Return
Short Term
-1.87 %
4.86 %
6.49 %
4.36 %
Long Term
Emcure Pharma Return Calculator
₹
Emcure Pharma Revenue and Profit and Growth
- The company's Book Value Per Share (BVPS) is improving consistently for last 2 years
- The company is showing good quarterly growth with YoY Net Profit Growth of 30.93%, the YoY Revenue Growth of 21.49% and the NetProfit for the last quarter of Rs. 127.37 Cr.
- The stock price of the company is lurking near its 52 week low
- RSI of the company is 33.91